التفاصيل البيبلوغرافية
| العنوان: |
Invasive group A streptococcal disease surveillance in Canada, 2020. |
| المؤلفون: |
Golden, Alyssa, Griffith, Averil, Demczuk, Walter, Tyrrell, Gregory, Kus, Julianne, McGeer, Allison, Domingo, Marc-Christian, Hoang, Linda, Minion, Jessica, Van Caeseele, Paul, Smadi, Hanan, Haldane, David, Zahariadis, George, Mead, Kristen, Steven, Laura, Strudwick, Lori, Li, Anita, Mulvey, Michael, Martin, Irene |
| المصدر: |
Canada Communicable Disease Report; Sep2022, Vol. 48 Issue 9, p407-414, 8p |
| مصطلحات موضوعية: |
STREPTOCOCCAL diseases, TOXIC shock syndrome, RHEUMATIC fever, STREPTOCOCCUS pyogenes, DRUG resistance in microorganisms, DISEASE incidence |
| مصطلحات جغرافية: |
CANADA |
| الشركة/الكيان: |
CENTERS for Disease Control & Prevention (U.S.) |
| مستخلص: |
Background: Invasive group A streptococcal (iGAS) disease (caused by Streptococcus pyogenes) has been a nationally notifiable disease in Canada since 2000. This report summarizes the demographics, emm types and antimicrobial resistance of iGAS infections in Canada in 2020. Methods: The Public Health Agency of Canada's National Microbiology Laboratory (Winnipeg, Manitoba) collaborates with provincial and territorial public health laboratories to conduct national surveillance of invasive S. pyogenes. Emm typing was performed on all isolates using the Centers for Disease Control and Prevention emm sequencing protocol. Antimicrobial susceptibilities were determined using Kirby-Bauer disk diffusion according to Clinical and Laboratory Standards Institute guidelines. Population-based iGAS disease incidence rates up to 2019 were obtained through the Canadian Notifiable Disease Surveillance System. Results: Overall, the incidence of iGAS disease in Canada has increased from 4.0 to 8.1 cases per 100,000 population from 2009 to 2019. The 2019 incidence represents a slight decrease from the 2018 rate of 8.6 cases per 100,000 population. A total of 2,867 invasive S. pyogenes isolates that were collected during 2020 are included in this report, representing a decrease from 2019 (n=3,194). The most common emm types in 2020 were emm49 (16.8%, n=483) and emm76 (15.0%, n=429), both increasing significantly in prevalence since 2016 (p<0.001). The former most prevalent type, emm1, decreased to 7.6% (n=217) in 2020 from 15.4% (n=325) in 2016. Antimicrobial resistance rates in 2020 included 11.5% resistance to erythromycin, 3.2% resistance to clindamycin and 1.6% nonsusceptibility to chloramphenicol. Conclusion: Though the number of collected invasive S. pyogenes isolates decreased slightly in 2020 in comparison to previous years, iGAS disease remains an important public health concern. The emm distribution in Canada has been subtly shifting over the past five years, away from common and well-known emm1 and towards emm49 and emm76. It is important to continue surveillance of S. pyogenes in Canada to monitor expanding replacement emm types, as well as outbreak clones and antimicrobial resistance. [ABSTRACT FROM AUTHOR] |
|
Copyright of Canada Communicable Disease Report is the property of Public Health Agency of Canada and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder